CAAP Rule and Prescription Drug Prices
This article describes a recently finalized CMS rule addressing the permissibility of co-pay accumulator adjustment programs (CAAPs) when no generic is available.
Preferences for and Experiences With Pill Appearance Changes: National Surveys of Patients and Pharmacists
Changes in generic drug appearance occur often. Patients’ and pharmacists’ responses to those changes vary, with some patients stopping their medication or using it less.
Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011
From 2001 to 2011, the US Food and Drug Administration approved 9 single-enantiomer drugs with racemic precursors. None showed pre-approval evidence of improved efficacy over the racemic precursor.
